Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
A team of researchers at Massachusetts's Institute of Technology in Cambridge developed a portable production system that can immediately manufacture a variety of biopharmaceuticals, according to MIT News.
Britain-based GlaxoSmithKline and Verily Life Sciences will enter the bioelectronic medicine market with the formation of a new biotech called Galvani Electronics.
With the end of the second quarter wrapping up, drug industry giants are reporting a variety of financial results.
Here are the four latest drugs approved by the Food and Drug Administration.
The Food and Drug Administration approved Glenmark Pharamceuticals' potassium chloride tablets.
Claris Injectibles, a subsidiary of India-based Claris Lifesciences Limited, earned Food and Drug Administration approval for its bupivacaine hydrochloride injectable medication.
The Food and Drug Administration approved Sanofi's new drug Adlyxin to treat adults with type 2 diabetes.
GlaxoSmithKline purchased the global rights to an experimental asthma drug from Johnson & Johnson for $230 million, according to Reuters.
Texas hospitals are feeling the effects of the national blood shortage.
Merck reported an unexpected revenue increase in the second quarter due to the success of its cancer drug Keytruda and new hepatitis treatments.